
结论很明确:这个市场不适合进入,已经是明显的价格战区,而且新品牌几乎没有真实成功空间。 你虽然有50万人民币,足够覆盖单个ASIN的首轮投入,但这不是“能不能做”的问题,而是“做了大概率赚不到钱”的问题;对大品牌和小企业都不友好,当前应直接回避。
从数据看,市场已经偏向过度拥挤且利润被压薄:共有17个新品牌、18个老品牌,新增品牌已经不少;新发布产品共91个,但新发布可盈利率只有13.19%,其中新品牌的新发布盈利率是0%,新品牌新发布非盈利率100%。利润分布也很差,典型新产品利润率落在-7.77%、-5.17%、-2.03%、0.94%、4.53%这一带,远低于你要求的15%可接受线,说明这里不是健康竞争,而是典型的低毛利硬拼市场。时间上也在变坏:2025年和2026年持续有新产品涌入,但多数都在亏,最近入场并没有带来更好的利润,反而说明价格战压力在延续。
两类卖家都不该硬进:大品牌可以参考 Givifive 和 EnzeroTools 这类老品牌,但门槛高、投入重,且仍要面对持续压价。 Givifive 的老爆款 B0CBJTXH64 有22.05%利润率、月销8000、月收入15232000,B0FHZYGRK7 也有25.65%利润率、月收入1944000,属于靠老品牌积累和功能升级吃到的收益;而 MTABCTY 虽然做到了月销800和2000,对应 B0FXBH6DR8、B0FXBHQNX8 的利润率却只有-7.77%和-5.17%,Aokdom 的 B0GL5N9K3X 只有0.94%,B0GL5FQWRK 是4.53%,QZTYTY 的 B0FJ86PG33 为-2.03%、B0FJ86HQYH 为-7.88%,都不是可复制的健康小卖家样本。更关键的是,很多新品牌都没有利润,少数“看起来有销量”的款也已经接近或落入亏损区,说明若想靠小品牌正常打法进入,胜率极低,甚至需要接近掠夺式营销才可能硬撑。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不适合进入,用户预算虽然足够做单个ASIN的首轮投放,但市场已经进入明显的价格战和过度竞争状态。 这里不是“能不能付得起”的问题,而是“付得起也很难赚到钱”:新品牌新上架产品里,几乎没有真正跑出来的盈利案例,且新品牌新产品盈利率为0%,非盈利率为100%;同时,高竞争环境下的典型产品利润率只在-7.77%、-5.17%、-2.03%到4.53%之间,远低于你要求的15%可接受线。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,已经是明显的价格战区,且新品牌几乎没有成功案例。 现有数据里,新品牌新品盈利率为0%,新品牌新品非盈利率为100%;同时市场整体盈利难度被标成“高”,说明即使投入也很难跑出稳定利润。
这个市场不适合进入,结论很明确:已经是高压价格战市场,且没有看到足够多的稳定高利润新机会。 新品里只有13.19%达到“有销量且利润达标”,而新产品利润分布里,29.67%低于-10%,16.48%落在-10%到0%,10.99%只在20%~30%,也就是大量新入场产品要么亏钱,要么利润很薄,基本不是健康赛道。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0CBJTXH64 | Givifive | 2023-08-07 | Yes | $19.04 | 8000pcs | $152320.0 | 22.05% | $33586.56 | |
![]() | B0FHZYGRK7 | Givifive | 2025-08-15 | Yes | $19.44 | 1000pcs | $19440.0 | 25.65% | $4986.36 |
![]() | B0FZK8GLZ1 | Givifive | 2025-12-22 | Yes | $19.68 | 1000pcs | $19680.0 | 23.27% | $4579.54 |
![]() | B0FPX1QSH6 | Givifive | 2025-10-15 | Yes | $19.68 | 900pcs | $17712.0 | 25.6% | $4534.28 |
![]() | B0FVKDJSWN | Givifive | 2025-11-10 | Yes | $19.68 | 900pcs | $17712.0 | 24.69% | $4373.1 |
![]() | B0FY5NS5H1 | Givifive | 2025-12-09 | Yes | $19.68 | 900pcs | $17712.0 | 21.05% | $3728.38 |
![]() | B0FY5WJ3BH | Givifive | 2025-12-09 | Yes | $19.68 | 900pcs | $17712.0 | 20.9% | $3701.81 |
![]() | B0FT32DWDQ | Givifive | 2025-11-10 | Yes | $19.68 | 900pcs | $17712.0 | 20.73% | $3671.7 |
![]() | B0GXZJNHY8 | Givifive | 2026-06-05 | Yes | $19.68 | 800pcs | $15744.0 | 22.93% | $3610.1 |
![]() | B0FT2ZJ8P5 | Givifive | 2025-11-10 | Yes | $19.68 | 900pcs | $17712.0 | 17.47% | $3094.29 |
![]() | B0GYD5X9SC | EnzeroTools | 2026-06-01 | Yes | $17.05 | 700pcs | $11935.0 | 19.38% | $2313.01 |
![]() | B0CS5DDX5C | IHOTDER | 2024-02-12 | Yes | $12.96 | 600pcs | $7776.0 | 13.68% | $1063.76 |
![]() | B0D4LL9V59 | IHOTDER | 2024-07-01 | Yes | $12.96 | 600pcs | $7776.0 | 13.51% | $1050.54 |
![]() | B0FL783RVZ | Givifive | 2025-09-02 | Yes | $19.68 | 200pcs | $3936.0 | 25.7% | $1011.56 |
![]() | B0G5NPBNWQ | Givifive | 2026-01-13 | Yes | $19.68 | 100pcs | $1968.0 | 22.73% | $447.33 |
![]() | B0DS1RM1D7 | DDTPDE | 2025-01-02 | Yes | $15.68 | 100pcs | $1568.0 | 11.94% | $187.22 |
![]() | B0CKMTYRF8 | IHOTDER | 2023-11-23 | Yes | $12.77 | 50pcs | $638.5 | 12.26% | $78.29 |
![]() | B0CPV37JPG | IHOTDER | 2024-01-02 | Yes | $12.54 | 50pcs | $627.0 | 11.86% | $74.37 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FHZYGRK7 | Givifive | 2025-08-15 | Yes | $19.44 | 1000pcs | $19440.0 | 25.65% | $4986.36 |
![]() | B0FZK8GLZ1 | Givifive | 2025-12-22 | Yes | $19.68 | 1000pcs | $19680.0 | 23.27% | $4579.54 |
![]() | B0FPX1QSH6 | Givifive | 2025-10-15 | Yes | $19.68 | 900pcs | $17712.0 | 25.6% | $4534.28 |
![]() | B0FVKDJSWN | Givifive | 2025-11-10 | Yes | $19.68 | 900pcs | $17712.0 | 24.69% | $4373.1 |
![]() | B0FY5NS5H1 | Givifive | 2025-12-09 | Yes | $19.68 | 900pcs | $17712.0 | 21.05% | $3728.38 |
![]() | B0FY5WJ3BH | Givifive | 2025-12-09 | Yes | $19.68 | 900pcs | $17712.0 | 20.9% | $3701.81 |
![]() | B0FT32DWDQ | Givifive | 2025-11-10 | Yes | $19.68 | 900pcs | $17712.0 | 20.73% | $3671.7 |
![]() | B0GXZJNHY8 | Givifive | 2026-06-05 | Yes | $19.68 | 800pcs | $15744.0 | 22.93% | $3610.1 |
![]() | B0FT2ZJ8P5 | Givifive | 2025-11-10 | Yes | $19.68 | 900pcs | $17712.0 | 17.47% | $3094.29 |
![]() | B0GYD5X9SC | EnzeroTools | 2026-06-01 | Yes | $17.05 | 700pcs | $11935.0 | 19.38% | $2313.01 |
![]() | B0FL783RVZ | Givifive | 2025-09-02 | Yes | $19.68 | 200pcs | $3936.0 | 25.7% | $1011.56 |
![]() | B0G5NPBNWQ | Givifive | 2026-01-13 | Yes | $19.68 | 100pcs | $1968.0 | 22.73% | $447.33 |
这个市场不值得进入,结论很明确:新品牌几乎没有真实成功空间,且已经进入明显的价格战区。 核心数据非常直接:新产品总体盈利率只有13.19%,但新品牌的新发布产品盈利率是0%,新品牌新发布非盈利率是100%;同时,老品牌新发布产品里盈利率也只有32.43%,说明连强势玩家都在高压竞争下筛选极少数能打的款式。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入:已经进入价格战和过度拥挤状态,新品牌成功率只有13.19%,而且2025年后新进入明显增多、利润却在走弱。 对你这个单品场景来说,500000 CNY 看似够做启动,但面对这种回报结构,只会放大亏损风险,不适合大品牌或小企业硬闯。
从时间趋势看,市场在加速变难:2025年全年新发布91个,2026年已到31个新发布且大量是非盈利;按新品牌口径,最近看到的盈利案例几乎被 Givifive 一家包揽,11个盈利新产品里占91.67%,其余新品牌基本都在亏。更关键的是,新增里大量产品利润率落在0%以下或0~10%区间,利润分布显示新产品中29.67%低于-10%,16.48%在-10%到0%,10.99%才到20%~30%,说明多数新品不是“能卖”,而是“卖得越多亏得越久”。
对两类卖家结论都很明确:大品牌要拿Givifive这类旧品牌做标杆,但进入也需要显著预算和长期品牌投入;小企业若想靠“真正的新品牌”成功,几乎没有可复制的健康样本,反而更像被挤压的市场。 具体看案例,Givifive 的老品 B0CBJTXH64 仍有22.05%利润率、月销8000、月收入15232000,但这是老牌积累;新上来的 MTABCTY(B0FXBH6DR8 / B0FXBHQNX8)虽然月销做到800~2000,却利润率分别是-7.77%和-5.17%,Aokdom 的 B0GL5N9K3X 只有0.94%,QZTYTY 的 B0FJ86PG33 为-2.03%,B0FJ86HQYH 为-7.88%,并且很多新品牌还带着200+评论的异常高评论密度,属于典型的“高压打法”而不是健康小卖家。结论:不要进入;如果非要做,只能把它当作大品牌重金防守型项目,且仍然没有高胜率保证。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 8 | 6 | 3 | 1 | 8 | 0 | 0 | 24 |
| 2026 | 3 | 1 | 3 | 1 | 2 | 0 | 0 | 31 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/8 | 5 | 2 | 1 | 0 | 1 | 0 | 0 | 4 |
| 2025/9 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 2 |
| 2025/10 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 3 |
| 2025/11 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
| 2025/12 | 2 | 3 | 1 | 0 | 3 | 0 | 0 | 13 |
| 2026/1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 7 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 11 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| 2026/5 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 |
| 2026/6 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 |